CRISPR screens reveal YAP/TEAD axis as a mediator of drug-tolerant cells in EGFR-mutant NSCLC

Related articles

1. Combined inhibition of BETs and HDACs as a potential epigenetics-based therapy for malignant rhabdoid tumor

   This article has 12 authors:

   1. Zebing Liu
   2. Lingyan Zhu
   3. Yuanyuan Li
   4. Yaxian Wen
   5. Jinxuan Wen
   6. Junzhu Zhang
   7. Lingzhao Min
   8. Changsheng Li
   9. Qi Peng
   10. Lisha Wang
   11. Anqi Li
   12. Xiaoqiang Wang

2. CRISPR and Compound Screens in a Novel Ex Vivo Tissue Model Identify DDR1 and ETA as Regulators of Cancer Cell Invasion

   This article has 16 authors:

   1. Junnan Liu
   2. Wencheng Jiang
   3. Xue Wang
   4. Anca Azoitei
   5. Hengchuan Liu
   6. Gregoire Najjar
   7. Kuangzheng Liu
   8. Michael Karl Melzer
   9. Stephan Stilgenbauer
   10. Mohamed Elati
   11. Martin D. Burkhalter
   12. Melanie Philipp
   13. Felix Wezel
   14. Friedemann Zengerling
   15. Christian Bolenz
   16. Cagatay Günes

3. TET1 suppresses hepatocellular carcinoma progression by modulating the PI3K/Akt signaling pathways

   This article has 13 authors:

   1. Shuaiyong Qi
   2. Ming Chen
   3. Zhixian Ding
   4. Mike Dai
   5. Lusheng Wang
   6. Jie Chen
   7. Yu Tang
   8. Mengxue Hu
   9. Yafei Li
   10. Kemeng Tan
   11. Lili Li
   12. Hui Jiang
   13. Heng Tang